Tender Overview
Employees State Insurance Corporation (ESIC), conducting a procurement in Ahmedabad, Gujarat, invites bids for specified injectable oncology products including Inj Cetuximab 100 mg, NS Glass Bottle 500 ml, NS Glass Bottle 250 ml, Inj Eribulin 1 mg, and Inj Vincristine 1 mg. Estimated contract value: ₹937,852.00. EMD: ₹5.0 (DD accepted). Quantity variation clause allows up to 25% increase during contract and up to 25% during currency term. Hard copy required within 5 days of bid end/opening. Delivery period linked to order timing; option clause governs extended timelines.
Technical Specifications & Requirements
- Items: Cetuximab 100 mg, NS Glass Bottles 500 ml, NS Glass Bottles 250 ml, Eribulin 1 mg, Vincristine 1 mg.
- No explicit technical specs published; procurement scope covers listed injectable drugs and glass packaging.
- EMD submission via Account Payee Demand Draft in favour of ESIFund A/c 1, payable at Ahmedabad; scanned DD proof to be uploaded; hardcopy to Buyer within 5 days post bid end/opening.
- At bidder level, be prepared to comply with standard government delivery/quality expectations and option-based quantity adjustments.
Terms, Conditions & Eligibility
- EMD: ₹5 or equivalent via DD; submission proof required with bid.
- Delivery: Delivery schedule to be aligned with last delivery order date; extended time as per option clause.
- Payment Terms: Not explicitly stated; standard approach applies (to be confirmed in ATC).
- Documentation: DD for EMD, proof of delivery, and hardcopy submission within 5 days; forms per ATC.
- Eligibility: Compliance with at least basic pharmaceutical supply norms; ensure OEM/authorized supplier status if required.
- Warranty/Penalties: Not detailed; expect standard ESIC penalties for delay within contract terms.